Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia

2021/04/26 by Eliza Yankova, Wesley Blackaby, Mark R. Albertella +26 · 15 citations
Biochemistry, Genetics and Molecular Biology · #Cancer-related gene regulation #RNA Research and Splicing #RNA modifications and cancer

paper · doi:10.1038/s41586-021-03536-w

openalex publication_date 2021/04/26 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Citations

• Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
• <i>Phaser</i>crystallographic software

Cited by

• A Chemically Induced CRISPR/dCas13 FCPF Platform for Precise and Programmable RNA Regulation
• Epitranscriptomic advances in normal and malignant hematopoiesis
• FOCAS: Transcriptome-wide screening of individual m6A sites functionally dissects epitranscriptomic control of gene expression in cancer
• Discovery of CRBN-recruiting PROTAC degraders of the METTL3-METTL14 complex
• Cell Marker Accordion: interpretable single-cell and spatial omics annotation in health and disease
• Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia
• METTL3 obstructs vascular smooth muscle cells osteogenic reprogramming by methylating Runx2 in chronic kidney disease
• METTL3-targeted intervention on nuclear factors RORA/RORγt suppresses pathogenic T helper 17 cell differentiation and alleviates kidney damage in lupus nephritis
• EZH2 crosstalk with RNA methylation promotes prostate cancer progression through modulation of m6A autoregulation pathway
• Epigenetics-targeted drugs: current paradigms and future challenges
• tRNA modifications tune m6A-dependent mRNA decay
• RNA‐Binding Proteins and Ferroptosis in Cancer: Mechanism and Therapeutic Implications
• Calibrated analysis framework for nanopore direct RNA sequencing uncovers cell-specific m⁶A stoichiometry at conserved sites
• Inhibition of <i>Clostridioides difficile-</i> specific DNA adenine methyltransferase CamA by analogs of <i>S</i> -adenosyl-L-methionine
• CRISPR-based functional genomics for dissecting therapeutic dependency in primary acute myeloid leukemia samples